Healthcare Stocks

Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

 Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its life sciences sector in 2021, with VC (Venture Capital) and PE (Private Equity) investment into th...

Read More...
Focus on healthcare stocks in 2020: AZN, GSK, HIK, SN., and CTEC

Focus on healthcare stocks in 2020: AZN, GSK, HIK, SN., and CTEC

Summary The British Healthcare sector has been on the forefront of the global fight against the pandemic, with, AstraZeneca Plc and GlaxoSmithKline Plc developing vaccines, that currently promise to be the earliest to be made available for mass ...

Read More...
Covid-19: UK PM Boris Johnson Optimistic About Vaccine to Hit the Market Soon

Covid-19: UK PM Boris Johnson Optimistic About Vaccine to Hit the Market Soon

Summary UK PM Boris Johnson is hoping the Covid-19 vaccine AZD1222 to hit the market sometime soon AstraZeneca has reached advance stages of vaccine development Vaccine might get all the mandatory approvals by the end of 2020 The economic...

Read More...
UK Plans to Create 4-Month Stockpiles of Protective Equipment

UK Plans to Create 4-Month Stockpiles of Protective Equipment

Summary Pharma industry has intimated the British government about the decreasing inventory of critical medicines and advised to buy and store in sufficient quantities in view of Brexit deadline During the mid of the Covid-19 crisis, NHS was un...

Read More...
A Pharmaceutical Stock Worth Looking at Amid the Corona Crisis

A Pharmaceutical Stock Worth Looking at Amid the Corona Crisis

Summary GlaxoSmithKline Plc is among the few spearheading the discovery of a potential vaccine to combat the deadly coronavirus. The pharmaceutical company spends a lot of money on research development every year to stay ahead of the competitio...

Read More...
Covid-19 vaccine race: AstraZeneca yet to resume US trials, Novavax starts phase 3 study

Covid-19 vaccine race: AstraZeneca yet to resume US trials, Novavax starts phase 3 study

The United States Food and Drug Administration (USFDA) is yet to give a go-ahead to AstraZeneca plc (LON: AZN) for restarting the clinical trial of its Covid-19 vaccine candidate, AZD1222, in the US. It is to be recalled that the pharmaceutical maj...

Read More...
Two FTSE Listed Healthcare Stocks in Limelight - Hikma Pharmaceuticals & Dechra Pharmaceuticals

Two FTSE Listed Healthcare Stocks in Limelight - Hikma Pharmaceuticals & Dechra Pharmaceuticals

Summary Hikma Pharmaceuticals generated revenue of USD 1,132 million, which was increased by 9 percent year on year in H1 FY20. The revenue in H1 FY20 was supported by strong demand for covid-19 related products in the US and Europe. Dechra Ph...

Read More...
Sanofi-GSK Signs Another Major Vaccine Deal with the EU For 300 Million Doses

Sanofi-GSK Signs Another Major Vaccine Deal with the EU For 300 Million Doses

Summary Sanofi-GSK entered a deal with the European Union for supplying as many as 300 million doses of their Coronavirus vaccine The vaccine candidate being perused by Sanofi and GSK is getting increased attention by governments worldwide beca...

Read More...
Medicinal Cannabis Companies Get Regulator’s Go Ahead to List On LSE

Medicinal Cannabis Companies Get Regulator’s Go Ahead to List On LSE

Summary The Financial Conduct Authority has allowed Medicinal Cannabis Companies to list on LSE The use of cannabis for recreation activities continue to remain strictly prohibited In recent times, realising the medical importance, several cou...

Read More...
How Are the Frontrunners Faring in The Vaccine Race?

How Are the Frontrunners Faring in The Vaccine Race?

With every passing day, the race for the coronavirus vaccine is intensifying as most of the major vaccine candidates in the world have entered their third phase of clinical trials. It was the Russian vaccine Sputnik V developed by the Gamaleya Rese...

Read More...
Quick Insights on Two FTSE Listed Healthcare Stocks - Silence Therapeutics & EKF Diagnostics Holdings

Quick Insights on Two FTSE Listed Healthcare Stocks - Silence Therapeutics & EKF Diagnostics Holdings

Summary Silence Therapeutics made considerable advancements in the development of SLN360 and SLN124 in H1 FY2020. It got FDA approval for dose escalation of SLN360. The Company entered into a partnership with AstraZeneca for the development and...

Read More...